What is Kinnos?
Kinnos is a specialized healthcare technology firm that has developed Highlight, a transformative solution designed to enhance the reliability of disinfection practices. By integrating a visible color additive into standard disinfectants, the technology provides real-time visual confirmation of surface coverage, effectively eliminating the guesswork often associated with manual cleaning protocols. This innovation is particularly vital in high-stakes environments such as hospitals and clinical facilities, where thorough sanitation is the primary defense against healthcare-associated infections. By standardizing cleaning performance and improving technique, Kinnos enables healthcare providers to maintain safer environments for both patients and staff without disrupting existing clinical workflows.
How much funding has Kinnos raised?
Kinnos has raised a total of $22M across 3 funding rounds:
Angel/Seed
$1M
Other Financing Round
$6M
Other Financing Round
$15M
Angel/Seed (2017): $1M, investors not publicly disclosed
Other Financing Round (2020): $6M led by Golden Seeds, Allston Venture Fund, Partnership Fund for New York City, Prolog Ventures LLC, and MEDA Angels
Other Financing Round (2023): $15M supported by Kapor Center
Key Investors in Kinnos
Kapor Center
A justice-oriented organization that invests in early-stage startups through Kapor Capital, focusing on closing gaps of access and promoting equity within the technology sector.
Golden Seeds
A New York-based venture capital firm specializing in start-up, early-stage, and growth capital investments with a broad national presence.
Partnership Fund for New York City
A nonprofit organization that mobilizes the private sector to support emerging industries and economic innovation, acting as a catalyst for urban growth and job creation.
What's next for Kinnos?
With the recent influx of capital, Kinnos is well-positioned to accelerate its market penetration and expand its footprint within the global healthcare sector. The strategic focus will likely shift toward scaling production, broadening the adoption of the Highlight technology across diverse medical facilities, and potentially exploring new applications for its color-coded disinfection methodology. As the company transitions into this mature phase of its lifecycle, the emphasis will remain on data-driven outcomes and the continued refinement of its product suite to meet the evolving demands of modern infection control. By leveraging its strong investor base, Kinnos is poised to set a new benchmark for hygiene standards in the enterprise healthcare market.
See full Kinnos company page
